1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Interpretable machine learning model based on the systemic inflammation response index and ultrasound features can predict central lymph node metastasis in cN0T1–T2 papillary thyroid carcinoma

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          It is arguable whether individuals with T1–T2 papillary thyroid cancer (PTC) who have a clinically negative (cN0) diagnosis should undergo prophylactic central lymph node dissection (pCLND) on a routine basis. Many inflammatory indices, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and systemic immune-inflammatory index (SII), have been reported in PTC. However, the associations between the systemic inflammation response index (SIRI) and the risk of central lymph node metastasis (CLNM) remain unclear.

          Methods

          Retrospective research involving 1,394 individuals with cN0T1–T2 PTC was carried out, and the included patients were randomly allocated into training (70%) and testing (30%) subgroups. The preoperative inflammatory indices and ultrasound (US) features were used to train the models. To assess the forecasting factors as well as drawing nomograms, the least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression were utilized. Then eight interpretable models based on machine learning (ML) algorithms were constructed, including decision tree (DT), K-nearest neighbor (KNN), support vector machine (SVM), artificial neural network (ANN), random forest (RF), extreme gradient boosting (XGBoost), light gradient boosting machine (LightGBM), and categorical boosting (CatBoost). The performance of the models was evaluated by incorporating the area under the precision-recall curve (auPR) and the area under the receiver operating characteristic curve (auROC), as well as other conventional metrics. The interpretability of the optimum model was illustrated via the shapley additive explanations (SHAP) approach.

          Results

          Younger age, larger tumor size, capsular invasion, location (lower and isthmus), unclear margin, microcalcifications, color Doppler flow imaging (CDFI) blood flow, and higher SIRI (≥0.77) were independent positive predictors of CLNM, whereas female sex and Hashimoto thyroiditis were independent negative predictors, and nomograms were subsequently constructed. Taking into account both the auROC and auPR, the RF algorithm showed the best performance, and superiority to XGBoost, CatBoost and ANN. In addition, the role of key variables was visualized in the SHAP plot.

          Conclusions

          An interpretable ML model based on the SIRI and US features can be used to predict CLNM in individuals with cN0T1–T2 PTC.

          Related collections

          Most cited references37

          • Record: found
          • Abstract: found
          • Article: not found

          Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

          This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer. Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers. Overall incidence was from 2-fold to 3-fold higher in transitioned versus transitioning countries for both sexes, whereas mortality varied <2-fold for men and little for women. Death rates for female breast and cervical cancers, however, were considerably higher in transitioning versus transitioned countries (15.0 vs 12.8 per 100,000 and 12.4 vs 5.2 per 100,000, respectively). The global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020, with a larger increase in transitioning (64% to 95%) versus transitioned (32% to 56%) countries due to demographic changes, although this may be further exacerbated by increasing risk factors associated with globalization and a growing economy. Efforts to build a sustainable infrastructure for the dissemination of cancer prevention measures and provision of cancer care in transitioning countries is critical for global cancer control.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Big data and machine learning algorithms for health-care delivery

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020

                Bookmark

                Author and article information

                Journal
                Gland Surg
                Gland Surg
                GS
                Gland Surgery
                AME Publishing Company
                2227-684X
                2227-8575
                17 November 2023
                24 November 2023
                : 12
                : 11
                : 1485-1499
                Affiliations
                [1 ]deptDepartment of Breast and Thyroid Surgery, Third Xiangya Hospital , Central South University , Changsha, China;
                [2 ]deptDepartment of Urology, Third Xiangya Hospital , Central South University , Changsha, China;
                [3 ]deptDepartment of General Surgery, Third Xiangya Hospital , Central South University , Changsha, China
                Author notes

                Contributions: (I) Conception and design: L Qian, J Pang; (II) Administrative support: L Qian; (III) Provision of study materials or patients: J Pang, M Yang; (IV) Collection and assembly of data: J Li, X Zhong, X Shen, T Chen; (V) Data analysis and interpretation: J Pang, M Yang, L Qian; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

                Correspondence to: Liyuan Qian, MD. Department of Breast and Thyroid Surgery, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, China. Email: qianliyuan2014@ 123456126.com .
                [^]

                ORCID: 0009-0003-9720-3647.

                Article
                gs-12-11-1485
                10.21037/gs-23-349
                10721554
                38107491
                b391fc6d-91d8-45c5-ad54-db8c93ddffce
                2023 Gland Surgery. All rights reserved.

                Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

                History
                : 23 August 2023
                : 02 November 2023
                Categories
                Original Article

                central lymph node metastasis (clnm),papillary thyroid cancer (ptc),systemic inflammation response index (siri),machine learning (ml),shapley additive explanations (shap)

                Comments

                Comment on this article